NuCana (NCNA) Expected to Announce Earnings on Wednesday

NuCana (NASDAQ:NCNA) is projected to post its quarterly earnings results before the market opens on Wednesday, March 19th. Analysts expect NuCana to post earnings of ($2.43) per share for the quarter.

NuCana Trading Up 9.1 %

Shares of NASDAQ:NCNA opened at $0.83 on Tuesday. The company has a market cap of $2.19 million, a price-to-earnings ratio of -0.08 and a beta of 0.89. NuCana has a 12 month low of $0.75 and a 12 month high of $10.79. The company has a 50-day moving average price of $0.99 and a 200 day moving average price of $1.59.

About NuCana

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells.